TENAX THERAPEUTICS, INC. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
TENAX THERAPEUTICS, INC. (TENX) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals of $81.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $81.00K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $329.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $307.00K; Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals as first filed $307.31K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $300.35K; Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals as first filed $1.41M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals as first filed |
|---|---|---|
| 2025-12-31 | $81.00K 10-K · filed 2026-03-10 | |
| 2024-12-31 | $329.00K 10-K · filed 2026-03-10 | |
| 2023-12-31 | $307.00K 10-K · filed 2025-03-25 | $307.31K 10-K · filed 2024-03-28 |
| 2022-12-31 | $300.35K 10-K · filed 2024-03-28 | $1.41M 10-K · filed 2023-03-31 |
| 2021-12-31 | $308.30K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $545.23K 10-K · filed 2022-03-29 | |
| 2019-12-31 | $498.57K 10-K/A · filed 2021-04-16 | |
| 2018-12-31 | $509.07K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $567.09K 10-K · filed 2019-04-01 | |
| 2016-12-31 | $902.55K 10-K · filed 2018-04-02 | |
| 2015-12-31 | $691.34K 10-K · filed 2017-03-16 | |
| 2015-04-30 | $618.40K 10-KT · filed 2016-03-14 | |
| 2014-04-30 | $230.90K 10-KT · filed 2016-03-14 | |
| 2013-04-30 | $336.63K 10-K · filed 2014-07-29 | |
| 2012-04-30 | $244.21K 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |